African Union pledges Bundibugyo Ebola vaccine by year-end as deaths reach 246

246 deaths confirmed with 1,077 suspected cases; healthcare workers operating with severe resource shortages while managing populations unable to conduct traditional funerals due to transmission risk.
Healthcare workers fighting with minimal resources, families unable to bury their dead
The outbreak is complicated not just by the virus itself, but by the collision between medical necessity and cultural practice.

No meio das florestas e conflitos do leste do Congo, um surto de Ébola Bundibugyo — cepa sem vacina aprovada — já ceifou 246 vidas e acumula mais de mil casos suspeitos, ameaçando tornar-se o segundo maior da história. A União Africana respondeu com uma promessa pública: vacina e tratamento disponíveis antes do fim de 2026. É o momento em que a humanidade, mais uma vez, se vê a correr contra um vírus enquanto tenta conciliar ciência, solidariedade internacional e o peso das tradições que não se rendem facilmente ao imperativo da contenção.

  • Com 246 mortos e 1.077 casos suspeitos, o surto avança a um ritmo que pode torná-lo o segundo maior de Ébola Bundibugyo alguma vez registado.
  • O vírus cruzou fronteiras: Uganda confirmou sete casos na capital Kampala e fechou temporariamente a fronteira com a RDC, enquanto dez nações vizinhas entram em alerta elevado.
  • Os profissionais de saúde combatem a epidemia com equipamentos escassos, sem vacina nem tratamento aprovados, e enfrentam resistência cultural das populações que recusam abandonar os rituais fúnebres tradicionais.
  • A resposta internacional acelera: a UE enviou equipamentos de proteção para Bunia, os EUA anunciaram mais 80 milhões de dólares em apoio e a OMS declarou emergência de saúde pública de âmbito internacional.
  • A União Africana comprometeu-se publicamente a garantir vacina e medicamento contra o Bundibugyo até ao final de 2026, oferecendo um horizonte concreto numa crise ainda em expansão.

O número de mortos pelo Ébola Bundibugyo chegou a 246, com mais de mil casos suspeitos espalhados pelo leste da República Democrática do Congo e já presentes em Uganda. Na quinta-feira, enquanto os números subiam, a União Africana assumiu um compromisso público: vacina e tratamento para esta estirpe estarão disponíveis antes do fim do ano.

Jean Kaseya, diretor-geral do Africa CDC, fez o anúncio durante uma conferência em Kinshasa. A declaração ganhou peso porque o surto avança a um ritmo que pode torná-lo o segundo maior da história do Ébola. Ainda assim, Kaseya garantiu que a situação permanece controlável. O vírus emergiu na província de Ituri, junto às fronteiras com Uganda e o Sudão do Sul, e alastrou entretanto para as províncias do Kivu. Uganda confirmou sete casos em Kampala — incluindo uma morte — e fechou temporariamente a fronteira com a RDC. Dez países africanos, entre eles Angola, encontram-se agora em situação de risco elevado.

No terreno, os profissionais de saúde trabalham com recursos mínimos. Sem vacina nem tratamento aprovados, a contenção depende quase exclusivamente do isolamento, da rastreabilidade de contactos e de equipamentos de proteção que escasseiam. A situação é agravada pelos conflitos regionais e por uma tensão cultural profunda: as populações locais recusam-se a abdicar dos rituais fúnebres tradicionais, que representam um risco significativo de transmissão.

A ajuda internacional começou a chegar na quinta-feira. A União Europeia enviou máscaras, luvas, botas e medicamentos para Bunia. Os Estados Unidos anunciaram um reforço de 80 milhões de dólares, elevando o total comprometido desde o início do surto para mais de 112 milhões. A OMS declarou emergência de saúde pública de preocupação internacional, e o seu diretor-geral viaja para a RDC para avaliar a resposta no local.

A promessa de uma vacina até ao final de 2026 oferece um horizonte concreto, mas os desafios de desenvolvimento e produção em escala são consideráveis. Enquanto isso, o número de mortos continua a crescer e os profissionais de saúde tentam convencer famílias em luto de que a forma como sempre honraram os seus mortos terá, por agora, de esperar.

The death toll from Ebola Bundibugyo has climbed to 246, with another 1,077 suspected cases spreading across the eastern Democratic Republic of Congo and into neighboring Uganda. On Thursday, as the numbers climbed, the African Union made a public commitment: a vaccine and treatment for this particular strain will be available before the year ends.

Jean Kaseya, director-general of the Africa CDC—the African Union's public health agency—made the pledge during a conference in Kinshasa, the capital of the DRC. "What we are certain of," he said, "is that by the end of 2026, the Africa CDC will ensure we have both a vaccine and a medicine against Bundibugyo." The statement carried weight because the outbreak is moving at a pace that could make it the second-largest Ebola epidemic in recorded history. Yet Kaseya insisted the situation remains manageable, not spiraling beyond control.

The virus emerged in Ituri province, which borders Uganda and South Sudan, but has since spread to the northern and southern Kivu provinces in the DRC's east. Uganda has confirmed seven cases, all in the capital Kampala, including one death—a Congolese citizen whose infection is believed to have been imported from across the border. The Ugandan government responded by temporarily closing its border with the DRC on Wednesday. Ten African nations, including Angola, now sit in a category of heightened risk, sharing borders with either the DRC or Uganda.

On the ground, healthcare workers are fighting the virus with minimal resources. Bundibugyo has no approved vaccine or treatment, which makes containment depend almost entirely on isolation, contact tracing, and protective equipment that remains in short supply. The work is further complicated by regional conflict and by a cultural collision: local populations are refusing to accept restrictions on funeral practices, which carry significant transmission risk. Families want to bury their dead according to tradition; public health demands they cannot.

International assistance began arriving Thursday. A plane from the European Union delivered masks, gloves, boots, and medications to Bunia, in the DRC's east. UN equipment was being loaded onto trucks bound for affected areas. The EU aid is expected to arrive in batches over the next eight days, according to Jérôme Kouachi, emergency operations chief for UNICEF in the DRC. The United States announced a substantial increase in support: an additional $80 million in aid to the DRC and Uganda, bringing its total commitment since the outbreak began to more than $112 million. That money will fund personal protective equipment for health workers, Ebola test kits, airport screening support, and contact tracing operations.

The World Health Organization has declared the outbreak a public health emergency of international concern—a designation meant to mobilize resources and attention globally. WHO Director-General Tedros Adhanom Ghebreyesus is traveling to the DRC to assess the response firsthand. The virus itself is unforgiving: it spreads through direct contact with bodily fluids from infected people or animals, causing severe hemorrhagic fever, vomiting, diarrhea, and internal bleeding. There is no cure, only supportive care and the hope that isolation prevents transmission.

The African Union's year-end vaccine pledge offers a concrete timeline, though vaccine development and manufacturing at scale remain formidable challenges. For now, the outbreak continues to spread, the death count rises, and healthcare workers operate in conditions of scarcity while trying to convince grieving families that the old ways of honoring the dead must wait.

By the end of 2026, the Africa CDC will ensure we have both a vaccine and a medicine against Bundibugyo
— Jean Kaseya, director-general of the Africa CDC
The epidemic is moving toward becoming the second-largest in history, but it is not out of control
— Jean Kaseya, Africa CDC
The Hearth Conversation Another angle on the story
Inventor

Why is this particular strain—Bundibugyo—so significant compared to other Ebola variants?

Model

It's not that Bundibugyo is more lethal than other strains, but it's less familiar. The medical community has vaccines and treatments for Zaire and Sudan strains. This one has neither approved option yet. That's why the AU's promise of a vaccine by year-end matters so much—right now, containment is all they have.

Inventor

The source mentions cultural resistance to burial restrictions. How much is that actually slowing the response?

Model

It's a real friction point. Funerals are how communities process grief and honor their dead. Telling people they can't do that, even temporarily, creates resentment toward health authorities. Some people stop cooperating with contact tracing or isolation measures. It's not just a public health problem; it's a trust problem.

Inventor

Ten countries are at high risk. Does that mean we should expect the outbreak to spread beyond the DRC?

Model

It's a real possibility, but not inevitable. Uganda already has cases, but they've closed the border and are mobilizing resources. The question is whether neighboring countries can move fast enough with testing and isolation before cases arrive. The international aid suggests people are taking that risk seriously.

Inventor

The US is putting in over $112 million. Is that enough?

Model

Money alone doesn't stop an epidemic. It buys equipment, pays for workers, funds logistics. But if healthcare systems are already fragile and regional conflict is ongoing, money can only do so much. It's necessary but not sufficient.

Inventor

What does the AU's vaccine promise actually mean? Can they deliver?

Model

They're saying the Africa CDC will have it available by December. That's ambitious. Vaccine development usually takes years. Either they're confident in a candidate that's already in trials, or they're banking on rapid authorization of something that's been tested elsewhere. Either way, it's a public commitment that puts pressure on them to deliver.

Contact Us FAQ